by levi_hb | Dec 27, 2012 | Pharmaceutical meetings
CEO Andy McNeill and client, Christine Damico of Johnson & Johnson, talk about the changing face of pharmaceutical meetings. With many off-patent drugs coming up, cut-backs are discussed such as the size, length and frequency of face-to-face meetings. This...